TransDigm Group Inc. (0REK)
London Exchange · UK · prices in USD · close of 23 Oct 2026
Key indicators
| Last close | USD 1,099.84 |
|---|---|
| 52-week range | 1,050.00 – 1,472.43 |
| Return, 1 month / 3 months | −0.9% / −8.7% |
| Return, 1 year / 3 years | −18.0% / +56.1% |
| Trend | Below its 200-day average |
| RSI (14) | 42 |
| Volatility (1 year) | 26.0% |
| Worst drawdown (1 year) | -26.0% |
| Average daily value traded | 0.32M USD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
TransDigm Group is an aerospace company based in Cleveland, Ohio. It designs and produces proprietary aircraft components, including actuators, ignition systems, pumps, valves, and other engineered parts used on commercial and military aircraft. Its customers are mainly aircraft manufacturers, airlines, and maintenance providers, and it supplies both original equipment and aftermarket replacement parts. The company operates through a group of acquired businesses that each focus on specific aerospace component lines.
The shares are listed on the London Exchange in UK under the code 0REK, and the price on this page is in US dollars (USD). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
TransDigm Group Inc. (0REK) trades on the London Exchange in UK. It last closed at USD 1,099.84 on 23 October 2026.
Its price-based Market X-Ray is 42 out of 100 (a weak price profile), ranking 2,543 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 18.0% and over the last three months it fell 8.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 30 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -10.7% | ||
| From 52-week high | -24.5% | ||
| Momentum | 30 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -8.7% | ||
| 6-month return | -5.5% | ||
| 12-month return, skipping the last month | -17.3% | ||
| Stability (higher is calmer) | 65 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 26.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.0% | ||
| Liquidity | 41 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.32M USD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −3.7% |
|---|---|
| 1 month | −0.9% |
| 3 months | −8.7% |
| 6 months | −5.5% |
| 1 year | −18.0% |
| 3 years | +56.1% |
| 5 years | +104.9% |
Signals
| 50-day / 200-day average | 1,137.29 / 1,232.29 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 41.30 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Sep 2025 | USD 90.0000 |
| 4 Oct 2024 | USD 75.0000 |
| 17 Nov 2023 | USD 35.0000 |
| 18 Aug 2022 | USD 18.5000 |
| 27 Dec 2019 | USD 32.5000 |
| 15 Aug 2019 | USD 30.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.